Furthermore, legumain is able to activate the secreted inactive proenzyme of matrix metalloproteinase-2 [9], [50], the role of which in tumor cell-mediated ECM proteolysis and metastasis has been well established [51]. The gene discussed is MMP2; the disease is neoplasm.